Renal Failure in the Neonate

Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 208-224

  Andreoli, Sharon P ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904220423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3163-5.50019-1     Document Type: Chapter

References (112)

1. Basile DP, Donohoe D, Roethe K, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term outcome. Am J Physiol 2001, 281:F887-F889.
2. Basile D Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing progressive nephropathy. Curr Opin Nephrol Hypertens 2004, 13:1-13.
3. Pryde PG, Sedman AB, Nugents CE, Basrr M Angiotensin converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993, 3:1575-1582.
4. Lip GYH, Churchill D, Beevers M, et al. Angiotensin converting enzyme inhibitors in early pregnancy. Lancet 1997, 350:1446-1447.
5. Martinovic J, Benachi A, Laurent N, et al. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 2001, 358:241-242.
6. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Eng J Med 2006, 354:2443-2451.
7. Benini D, Fanos V, Cuzzolin L, Tato L In utero exposure to nonsteroidal anti-inflammatory drugs: Neonatal acute renal failure. Pediatr Nephrol 2004, 19:232-234.
8. Hui-Stickle S, Brewer ED, Goldstein SL Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005, 45:96-101.
9. Mathews DE, West KW, Rescorla FJ, Vane DW, Grosfeld JL, Wappner RS, Bergstein J, Andreoli SP Peritoneal dialysis in the first 60 days of life. J Pediatr Surg 1990, 25:110-116.
10. Andreoli SP Acute renal failure. Curr Opin Pediatr 2002, 17:713-717.
11. Mogal NE, Brocklebank JT, Meadow SR A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 1998, 49:91-95.
12. Karlowivz MG, Adelman RD Nonoliguric and oliguric acute renal failure. Pediatr Nephrol 1995, 9:718-722.
13. Andreoli SP: Renal failure in the newborn init. In Polin RA, Yoder MC, Berg FD, (eds) Workbook in Practical Neonatology (pp. 322-337). Philadelphia, PA: W.B. Saunders Co., 2000.
14. Gouyon JB, Guignard JP Management of acute renal failure in newborns. Pediatr Nephrol 2000, 14:1037-1044.
15. Vanpee M, Blennow M, Linne T, Herin P, Aperia A Renal function in very low birth weight infants: Normal maturity reached during childhood. J Pediatr 1992, 121:784-788.
16. Drukker A, Guignard JP Renal aspects of the term and preterm infant: a selective update. Current Opinion in Pediatrics 2002, 14:175-182.
17. Goldstein SL Pediatric acute kidney injury: it's time for real progress. Pediatr Nephrol 2006, 21:891-895.
18. Martin-Ancel A, Garcia-Alix A, Gaya F, et al. Multiple organ involvement in perinatal asphyxia. J Pediatr 1995, 127:786-793.
19. Cataldi L, Leone R, Moretti U, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: A case controlled study. Arch Dis Child Fetal Neonatal Ed 2005, 90:514-519.
20. Aggarwal A, Kumar P, Chowkhary G, et al. Evaluation of renal function in asphyxiated newborns. J Trop Pediatr 2005, 51:295-299.
21. Cuzzolin L, Fanos V, Pinna B, et al. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006, 21:931-938.
22. Airede A, Bello M, Werasingher HD Acute renal failure in the newborn: Incidence and outcome. J Paediatr Child Health 1997, 33:246-249.
23. Nobilis A, Kocsis I, Toth-Heyn P, et al. Variance of ACE and AT1 receptor genotype does not influence the risk of neonatal acute renal failure. Pediatr Nephrol 2001, 16:1063-1066.
24. Vasarhelyi B, Toth-Heyn P, Treszl A, Tulassay T Genetic polymorphism and risk for acute renal failure in preterm infants. Pediatr Nephrol 2005, 20:132-135.
25. Treszl A, Toth-Heyn P, Koscic I. Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713-717, 2002.
26. Fekkete A, Treszl A, Toht-Heyn P, et al. Association between heat shock protein 72 gene polymorphism and acute renal failure in neonates. Pediatr Res 2003, 54:452-455.
27. Kelly KJ, Baird NR, Greene AL Induction of stress response proteins and experimental renal ischemia/reperfusion. Kidney Int 2001, 59:1798-1802.
28. Toth-Heyhn P, Dukker A, Guignard JP The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000, 14:227-239.
29. Andreoli SP Acute renal failure in the newborn. Seminars in Perinatology 2004, 28:112-123.
30. Badr KF, Ichikawa I Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med 1988, 319:623-628.
31. van Bel F, Guit GL, Schipper J, van de Bor M, Baan J Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991, 118:621-626.
32. Cifuentes RF, Olley PR, Balfe JW, Radde IC, Soldin SJ Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979, 95:583-587.
33. Allegaert K, Vanhole C, de Hoon J, et al. Nonselective cyclo-oxygensase inhibitors and glomerular filtration rate in preterm infants. Pediatr Nephrol 2005, 20:1557-1561.
34. Zanardo V, Vedovato S, Lago P, et al. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus. Pediatr Nephrol 2005, 20:1552-1556.
35. Gersony WM, Peckham GJ, Ellison RC, Miettienen OS, Nadas AS Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative stud. J Pediatr 1983, 102:895-906.
36. Itabashi K, Ohno T, Nishda H Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J Pediatr 2003, 143:203-207.
37. Brater DC Effects of nonsteroidial anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibitors. Am J Med 1999, 107:65S-71S.
38. Perazella MA, Eras J Are selective COX-2 inhibitors nephrotoxic?. Am J Kidney 2000, 35:937-940.
39. Tack ED, Perlman JM Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 1988, 112:805-810.
40. Wood EG, Bunchman TE, Lynch RE Captopril-induced reversible acute renal failure in an infant with coarctation of the aorta. Pediatrics 1991, 88:816-818.
41. Dutta S, Narnag A Enalapril induced acute renal failure in a newborn infant. Pediatr Nephrol 2003, 18:570-572.
42. Hricik DE, Dunn MJ Angiotensin converting enzyme inhibitor-induced acute renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990, 1:845-858.
43. Polito C, Papale MR, LaManna AL Long-term prognosis of acute renal failure in the full term newborn. Clin Pediatr 1998, 37:381-386.
44. Tulassay T, Vasarheleyi B Birth weight and renal function. Curr Opin Neph Hypertens 2002, 11:347-352.
45. Abitbol CL, Bauer CR, Montane B, et al. Long term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003, 18:887-893.
46. Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montane B, Zilleruelo G Comparative renal histomorphometry: A case study of oliogonephropathy of prematurity. Pediatr Nephrol 2005, 20:945-949.
47. Keijzer-Veen MG, et al. Microalbuminaria and lower glomerular filtration rate at young adult age in subjects born very prematurely and after intrauterine growth retardation. J Am Soc Nephrol 2005, 16:2762-2768.
48. Mathew OP, Jones AS, James E, Bland H, Groshong T Neonatal renal failure: Usefulness of diagnostic indices. Pediatrics 1980, 65:57-60.
49. Ellis EN, Arnold WC Use of urinary indexes in renal failure in the newborn. Am J Dis Child 1982, 136:615-617.
50. Perlman JM, Tack ED. Renal injury in the asphyxiated newborn infant: relationship to neurologic outcome. 113:875-879, 1988.
51. Stapleton FB, Jones DP, Green RS Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1987, 1:314-320.
52. Gallego N, Perez-Caballero C, Estepa R, Liano F, Ortuno J Prognosis of patients with acute renal failure without cardiomyopathy. Arch Dis Childhood 2001, 84:258-260.
53. Humes HD Aminoglycoside nephrotoxicity. Kidney Int 1988, 33:900-911.
54. Kasik JW, Leuschen MP, Bolam DL, Nelson RM Rhabdomyolysis and myoglobinemia in neonates. Pediatrics 1985, 76:255-258.
55. Watanabe T Rhabdomyolysis and acute renal failure in children. Pediatr Nephrol 2001, 16:1072-1075.
56. Andreoli SP Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991, 5:733-742.
57. Payne RM, Martin TC, Bower RJ, Canter CE Management and follow-up of arterial thrombosis in the neonatal period. J Pediatr 1989, 114:853-858.
58. Ellis D, Kaye RD, Bontempo FA Aortic and renal artery thrombosis in a neonate: Recovery with thrombolytic therapy. Pediatr Nephrol 1997, 11:641-644.
59. Chevalier RL What treatment do you advise for bilateral or unilateral renal thrombosis in the newborn, with or without thrombosis of the inferior vena cava?. Pediatr Nephrol 1991, 5:679.
60. Mocan H, Beattie TJ, Murphy AV Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 1991, 5:45-49.
61. Christensen AM, Daouk GH, Norling LL, Catlin EA, Ingelfinger JR Postnatal transient renal insufficiency in the feto-fetal transfusion syndrome. Pediatr Nephrol 1999, 13:117-120.
62. Cincotta RB, Gray PH, Phythian G, et al. Long term outcome of twin-twin transfusion syndrome. Arch Dis Child Fetal Med 2000, 83:F171-F176.
63. Beck M, Graf C, Ellenrieder B, et al. Long-term outcome of kidney function after twin-twin transfusion syndrome treated by intrauterine laser coagulation. Pediatr Nephrol 2005, 20:1657-1659.
64. Anand SK, Northway JD, Smith JA Neonatal renal papillary and cortical necrosis. Am J Dis Child 1977, 131:773-777.
65. Kellum JA Use of diuretics in the acute care setting. Kidney Int 1998, 53:67-70.
66. Denton MD, Chertow GM, Brady HR 'Renal-dose' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 1996, 49:4-14.
67. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?. Am J Med 1996, 101:498-553.
68. Low dose dopamine in patients with early renal dysfunction: a placebo controlled trial. Lancet 2000, 356:2139-2143. Australian and New Zealand Intensive Care Society Clinical Trials Group.
69. Kellum JA, Decker JM Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001, 29:1526-1531.
70. Galley HF Renal dose dopamine: will the message get through?. Lancet 2000, 356:2112-2113.
71. Lauschke A, Teichgraber UKM, Frei U, Eckardt KU 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006, 69:1669-1674.
72. Jenik AG, et al. A randomized, double blind, placebo-controlled trail of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 2000, 105:E45.
73. Bhat M, Shah ZA, Makidoomi MS, Mufti MH Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo controlled trial. J Pediatrics 2006, 149:180-184.
74. Bark AF, et al. Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia-a study in a developing country. Pediatr Nephrol 2005, 20:1249-1252.
75. Lemley KV Can theophylline prevent the development of renal dysfunction in neonates with severe asphyxia?. Nature Clinical Practice Nephrology 2006, 2:196-197.
76. Rodriguez-Soriano J Potassium homeostasis and its disturbances in children. Pediatr Nephrol 1995, 9:364-374.
77. Malone TA Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants. J Pediatr 1991, 118:121-123.
78. Singh BS, Sadiq HF, Noguchi A, Keenan WJ Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. J Pediatr 2002, 121:16-20.
79. Bunchman TE, Wood EG, Schenck MH, Weaver KA, Klein BL, Lynch RE Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake. Pediatr Nephrol 1991, 5:29-32.
80. Gerstman BB, Kirkman R, Platt R Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kid Dis 1992, 20:159-161.
81. Andreoli SP, Dunson JW, Bergstein JM Calcium carbonate is an effective phosphorus binder in children with chronic renal failure. Am J Kidney Dis 1987, 9:206-210.
82. Belsha CW, Kohaut EC, Warady BA Dialytic management of childhood acute renal failure: a survey of North American pediatric nephrologists. Pediatr Nephrol 1995, 9:361-363.
83. Steele BT, Vigneux A, Blatz D, Flavin M, Paes B Acute peritoneal dialysis in infants weighing <1500 g. J Pediatr 1987, 110:126-129.
84. Rainey KE, DiGeronimo R, Pascaul-Baralt J Successful long term peritoneal dialysis in a very low birth weight infant with renal failure secondary to feto-fetal transfusion syndrome. Pediatrics 2000, 106:849-852.
85. Golej J, Kitzmueller E, Herman M, Boigner H, Burda G, Trittenwein G Low-volume peritoneal dialysis in 116 neonatal and paediatic critical care patients. Eur J Pediatr 2002, 161:385-389.
86. Vaziri ND, Ness R, Wellikson L, Barton C, Greep N Bicarbonate-buffered peritoneal dialysis. An effective adjunct in the treatment of lactic acidosis. Am J Med 1979, 67:392-396.
87. McNiece KL, Ellis EE, Drummond-Webb JJ, Fontenot EE, et al. Adequacy of peritoneal dialysis in children following cardiopulmonary bypass surgery. Pediatr Nephrol 2005, 20:972-976.
88. Ledermann SE, Scanes ME, Fernando ON, et al. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000, 136:24-29.
89. Ellis EN, Pearson D, Champion B, Wood EG Outcome of infants on chronic peritoneal dialysis. Adv Perit Dial 1995, 11:266-269.
90. Donckerwolcke RA, Bunchman TE Hemodialysis in infants and small children. Pediatr Nephrol 1994, 8:103-106.
91. Sadowski RH, Harmon WE, Jabs K Acute hemodialysis of infants weighing less than five kilograms. Kidney Int 1994, 45:903-906.
92. Wigand C, Thompson T, Bock GH, Mathis RK, Kjellstrand CM, Mauer SM The management of life-threatening hyperammonemia. J Pediatr 1980, 116:125-128.
93. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Eng J Med 258-261, 1983.
94. Conger JF. Does hemodialysis delay recovery form acute renal failure?. Semin Dialy 1990, 3:146-147.
95. Arieff AI Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention. Kidney Int 1994, 45:629-635.
96. Silver SM, Sterns RH, Halperin ML Brain swelling after dialysis: Old urea or new osmoles?. Am J Kidney Dis 1996, 28:1-13.
97. Schulman G, Fogo A, Gung A, Badr K, Hakim R Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991, 40:1069-1074.
98. Cheung AK, Parker CJ, Wilcox L, Janatova J Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int 1989, 36:257-265.
99. Himmelfarb J, Lazarus M, Hakim R Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991, 17:271-276.
100. Lazarus JM, Owen WF Role of bio-incompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994, 24:1019-1032.
101. Verresen L, Waer M, Vanrenterghem Y, Michielsen P Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 1990, 336:1360-1362.
102. Brunet PH, Jaber K, Berland Y, Baz M Anaphylactoid reactions during hemodialysis and hemofiltration: Role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 1992, XIX:444-447.
103. Parnes EL, Shapiro WB Anaphylactoid reactions in hemodialysis patients treated with AN69 dialyzer. Kidney Int 1991, 40:1148-1152.
104. Forni LG, Hilton PJ Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997, 336:1303-1309.
105. Ronco C, Brendolan A, Bragantini L, Chiaramonte S, Feriani M, Fabris A, et al. Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. Kidney Int 1986, 29:908-915.
106. Zobel G, Rod S, Urlesberger B, et al. Continuous renal replacement therapy in critically ill neonates. Kidney Int 1998, 53:S169-S173.
107. Falk MC, Knight JF, Roy LP, Wilcken B, Schell DN, O'Connell AJ, et al. Continuous venovenous hemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 1994, 8:330-333.
108. Symons JM, Brophy PD, Gregory MJ, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kid Dis 2003, 984:989.
109. Askenazi DJ, Feig DI, Graham NM, et al. 3-5 year longitudinal follow up of pediatric patients with acute renal failure. Kidney Int 2006, 69:184-189.
110. Rodriguez-Soriano J, Aguirre M, Oliveros R, Vallo A Long-term follow-up of extremely low birth weight infants. Pediatr Nephrol 2005, 20:579-584.
111. Jones CA, Bowden LS, Watling R, et al. Hypercalcuria in ex-preterm children aged 7-8 years. Pediatr Nephrol 2001, 16:665-671.
112. Jones C, Judd B Long term follow-up of extremely low birth weight infants. Pediatr Nephrol 2006, 21:299.